Cargando…
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes
Regulation of food intake is a recently identified endocrine function of bone that is mediated by Lipocalin-2 (LCN2). Osteoblast-secreted LCN2 suppresses appetite and decreases fat mass while improving glucose metabolism. We now show that serum LCN2 levels correlate with insulin levels and β-cell fu...
Autores principales: | Mosialou, Ioanna, Shikhel, Steven, Luo, Na, Petropoulou, Peristera Ioanna, Panitsas, Konstantinos, Bisikirska, Brygida, Rothman, Nyanza J., Tenta, Roxane, Cariou, Bertrand, Wargny, Matthieu, Sornay-Rendu, Elisabeth, Nickolas, Thomas, Rubin, Mishaela, Confavreux, Cyrille B., Kousteni, Stavroula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537391/ https://www.ncbi.nlm.nih.gov/pubmed/32639539 http://dx.doi.org/10.1084/jem.20191261 |
Ejemplares similares
-
Lipocalin-2 is an anorexigenic signal in primates
por: Petropoulou, Peristera-Ioanna, et al.
Publicado: (2020) -
A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice
por: Luo, Na, et al.
Publicado: (2022) -
FoxO1-Dependent Induction of Acute Myeloid Leukemia by Osteoblasts in Mice
por: Kode, Aruna, et al.
Publicado: (2015) -
Whole-Slide Image Analysis of Human Pancreas Samples to Elucidate the Immunopathogenesis of Type 1 Diabetes Using the QuPath Software
por: Apaolaza, Paola S., et al.
Publicado: (2021) -
Improvements in Plasma Tumor Necrosis Factor-Alpha Levels after a Weight-Loss Lifestyle Intervention in Patients with Obstructive Sleep Apnea
por: Georgoulis, Michael, et al.
Publicado: (2022)